Valproate inhibits orofacial and somatic hyperalgesia induced by maternal separation through decreasing IL-6 expression in the medial prefrontal cortex and spinal cord in rats
European Journal of Pharmacology · 2026
DOI: 10.1016/j.ejphar.2026.178802 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2026. Verfasst von Yi Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, Xi'an Jiaotong University College of Stomatology, Xi'an, Shaanxi, 71…. Hauptthemen laut MEDLINE: Valproic Acid, Interleukin-6, Prefrontal Cortex, Hyperalgesia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Sodium valproate (VPA), a histone deacetylase (HDAC) inhibitor, has been shown to have analgesic effects and may be involved in analgesia through anti-inflammatory mechanisms. However, little is known about the involvement of VPA in the treatment of comorbid chronic pain conditions such as fibromyalgia syndrome (FMS) and temporomandibular disorder (TMD). In the present study, we used maternal separation (MS) stress model to simulate childhood stress-induced orofacial and somatic hyperalgesia at different age stages to mimic the overlapping pain symptoms of patients with TMD and FMS comorbidity. We found that MS stress induced consistent orofacial and somatic hyperalgesia in both male and female adolescent and adult rats, but there were no differences in the hyperalgesia between male and female rats post MS stress. MS stress increased protein expression of interleukin-6 (IL-6) in the medial prefrontal cortex (mPFC) and the dorsal horn of L4-L5 spinal cord segments. Intraperitoneal injection of VPA reversed MS stress-induced orofacial and somatic hyperalgesia as well as the increased expression of IL-6 in rats without sex differences. Conversely, microinjection of recombinant IL-6 protein into the mPFC or intrathecal injection reversed the analgesic effect of VPA. These results suggest that VPA may exert its therapeutic effects on orofacial and somatic hyperalgesia induced by MS through reducing IL-6 release.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, Xi'an Jiaotong University College of Stomatology, Xi'an, Shaanxi, 710004, China.
- Department of Neural and Pain Sciences, School of Dentistry; the UM Center to Advance Chronic Pain Research, University of Maryland Baltimore, Baltimore, MD, 21201, USA.
- Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, Xi'an Jiaotong University College of Stomatology, Xi'an, Shaanxi, 710004, China; Department of Neural and Pain Sciences, School of Dentist…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Guo, Y., Wei, S. Q., Li, J. H., Guo, W., Traub, R. J., & Cao, D. Y. (2026). Valproate inhibits orofacial and somatic hyperalgesia induced by maternal separation through decreasing IL-6 expression in the medial prefrontal cortex and spinal cord in rats. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2026.178802
Vancouver
Guo Y, Wei SQ, Li JH, Guo W, Traub RJ, Cao DY. Valproate inhibits orofacial and somatic hyperalgesia induced by maternal separation through decreasing IL-6 expression in the medial prefrontal cortex and spinal cord in rats. European Journal of Pharmacology. 2026. doi:10.1016/j.ejphar.2026.178802
BibTeX
@article{Guo2026,
author = {Guo, Yi and Wei, Si-Qi and Li, Jia-Heng and Guo, Wei and Traub, Richard J and Cao, Dong-Yuan},
title = {Valproate inhibits orofacial and somatic hyperalgesia induced by maternal separation through decreasing IL-6 expression in the medial prefrontal cortex and spinal cord in rats},
journal = {European Journal of Pharmacology},
year = {2026},
doi = {10.1016/j.ejphar.2026.178802}
}
EUVIMED